Oncology & Hematology Coding Alert

Reader Question:

Methotrexate Allows for E/M

  Question: If a physician administers an intramuscular injection of methotrexate and also conducts an office visit, should we use modifier -25 (Significant, separately identifiable E/M service by the same physician on the same day of the procedure or other service) with the E/M service? We wouldn't normally bill an E/M service when they do a simply injection like a flu shot, but for some reason there seems to be more involved in the injection of methotrexate. For example, our doctors say that the medical decision-making is higher. Indiana Subscriber Answer: Yes, an E/M service can and should be billed whenever an appropriate service is performed. If your physician has billed a service that includes history, physical examination and medical decision-making to support an E/M service, he should choose the appropriate code and bill for the service.

Chemotherapy administration in and of itself does not justify a certain level of E/M service, but it certainly contributes to the complexity of the medical decision-making for a visit and should be considered as the appropriate E/M code is chosen. In addition to the E/M service, you should bill 96400 (Chemotherapy administration, subcutaneous or intramuscular, with our without local anesthesia) for the administration of the drug.    
Codify by AAPC
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All
Subscribe to newsletter